2008 SPEAKER PRESENTATIONS
All presentations are Acrobat PDF files.
THURSDAY, FEBRUARY 14, 2008
PERFUSION: CHALLENGES & CHANGES
Point-of-Care Coagulation Testing
Julie A. Wegner CCP PhD
Isolated Limb Perfusion
Ian R. Shearer BS CCP LP
Controversies in Perfusion: What Should We Do about Them?
Robert C. Groom MSA CCP
The Changing Face of Perfusion
Alfred H. Stammers MSA CCP
BULLET ABSTRACTS
Cerebral Perfusion Effects Measured with Near-Infrared Spectroscopy in Adult Patients
Tobias Kühne
Reducing Gaseous Microemboli during Perfusion: Case Studies with the EDAC™ QUANTIFIER
John Edward (Ted) Lynch PhD
Serum Protein Levels in Children Undergoing Cardiac Surgery with the Use of
Cardiopulmonary Bypass
Molly Marko BS CCP
Data Management Systems for Quality Improvement in Patient Management
James M. Pezzuto RT(R) MBA CCP
Using Lepirudin as an Anticoagulant Instead of Heparin in Patients with Heparin-Induced Thrombocytopenia (HIT)
Behzad Saberi
FRIDAY, FEBRUARY 15, 2008
CUTTING-EDGE CARDIAC CARE: I
Transfusion-Related Risks (Permission to view slides denied by author/presenter)
George J. Despotis MD
Cardio-Aortic Disease: Open vs. Percutaneous Procedures
Lars G. Svensson MD PhD
Cardiovascular Stem-Cell Therapy 2007: Refractory Ischemia, AMI, and End-Stage Ischemic CHF
Timothy D. Henry MD
CUTTING-EDGE CARDIAC CARE: II
NIRS Monitoring to Determine Safe Minimum Flow Rate
Richard A. Jonas MD
Does Ventriculectomy for Dilated Ischemic Cardiomyopathy (DICM) Increase Survival?
L. Henry Edmunds Jr. MD
NEUROLOGICAL & END-ORGAN FUNCTION
Neurological Effects of CABG and LVAD: Acute, Sub-Acute and Chronic Sequelae
Ronald M. Lazar PhD
Neuroprotective Techniques
Alfred H. Stammers MSA CCP
Renal Protection and Dysfunction (Author/presenter not in attendance; see Brown for similar content)
Christina T. Mora-Mangano MD
SATURDAY, FEBRUARY 16, 2008
BLOOD AND BLEEDING: I
New Guidelines for Blood Transfusion and Conservation: The Process and Review
Bruce D. Spiess MD
Platelet Physiology
Julie A. Wegner CCP PhD
A Meta-Analysis Comparing the Effectiveness and Adverse Outcomes of Anti-Fibrinolytic Agents in Cardiac Surgery
Jeremiah R. Brown PhD
BLOOD AND BLEEDING: II
Clinical Impact of Platelet Gel Applications in Cardiac Surgery: From Enthusiasm to Reason
Serdar Gunaydin MD PhD
Ethics of Blood Management
Kathleen J. Sazama MD JD
KEYNOTE PRESENTATION
Resuscitating Afghanistan’s Healthcare System: The Need for Intelligent Perfusion of Aid to Win Hearts and Minds
(Slides not available; please check back soon)
Dave Warner MD PhD
SUNDAY, FEBRUARY 17, 2008
PRO/CON
Open vs. Closed CPB Systems
OPEN: Robert C. Groom MSA CCP
CLOSED: Julie A. Wegner CCP PhD
Perfusion Practice: Should It Be Limited to Cardiac Surgery?
PRO: Ian R. Shearer BS CCP LP
CON: Alfred H. Stammers MSA CCP